RT @kimitakatajimi: ACE阻害薬(アンジオテンシン変換酵素阻害、ARB(アンジオテンシンII受容体拮抗薬)は、COVID-19の死亡率を上げない。 ........ Cardiovascular Disease, Drug Therapy, and Mort…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @toyosh: 心血管系疾患、高血圧患者さんに対するACE阻害薬は、#COVID19 に対して、少なくとも有害ではない(むしろ有益)という大規模な観察研究がNEJMからpublishされました。懸念を払拭出来たことは大きいです。 https://t.co/QRCGmFg…
Rädslan för ACE-hämmare verkar ogrundad nu.
12/ACE inhibitors don't appear to harm coronavirus patients, according to this research. https://t.co/x9pOuUkPCo
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
Good
RT @mayogastro: Padecer de enfermedad cardiovascular es el factor de riesgo más importante de severidad en CoViD-19. Cuidados extremos en e…
RT @CharlieTomson: Three papers confirming what @RenalAssoc @escardio and others said all along: RAS inhibitors do not make people more lik…
RT @DrEkstrom: En av flera studier nu som inte visar på någon korrelation mellan användande av vissa blodtryckssänkande läkemedel (ACE-hämm…
RT @toyosh: 心血管系疾患、高血圧患者さんに対するACE阻害薬は、#COVID19 に対して、少なくとも有害ではない(むしろ有益)という大規模な観察研究がNEJMからpublishされました。懸念を払拭出来たことは大きいです。 https://t.co/QRCGmFg…
RT @JorgeRubenO: 🔷 La enfermedad cardiovascular subyacente se asocia con un mayor riesgo de muerte en el hospital en pacientes #COVID19 🔶…
RT @mayogastro: Padecer de enfermedad cardiovascular es el factor de riesgo más importante de severidad en CoViD-19. Cuidados extremos en e…
This observational database from 169 hospitals in Asia, Europe, and North America, evaluated the relationship of cardiovascular disease and drug therapy with in-hospital death among hospitalized patients with #COVID__19 https://t.co/8J08n7huLm @NEJM @ESC_
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
心血管系疾患、高血圧患者さんに対するACE阻害薬は、#COVID19 に対して、少なくとも有害ではない(むしろ有益)という大規模な観察研究がNEJMからpublishされました。懸念を払拭出来たことは大きいです。
RT @MRMehraMD: Many Questions, Varying Opinions, now some data-driven answers - How do Cardiac Medications modify outcome in COVID-19? Card…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 | NEJM https://t.co/NivFRsh0ZT
RT @t_hudali: Correlation doesn’t always mean causation! #MedEd #MedTwitter #FOAMed #COVID #Statistics https://t.co/PyuBQ9MOx1
RT @ernestocardio: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 | NEJM https://t.co/I4ljIVGkB6 @mencardio @torresviera @…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
Correlation doesn’t always mean causation! #MedEd #MedTwitter #FOAMed #COVID #Statistics
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @DanielJDrucker: “Our results did not confirm previous concerns regarding a potential harmful association of ACE inhibitors or ARBs with…
En 3 estudios publicados recientemente en @NEJM se indica que no hay evidencia de que los #IECA o los #ARAII incrementen el riesgo de tener #COVIDー19. #COVID19mx
RT @ABsteward: In this large population based study @NEJM Using database from 169 hospitals in Asia, Europe, and North America"~9000 patien…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @ethanjweiss: Maybe don't stop the statin? https://t.co/Gnp9WieRc1 https://t.co/iqX9ZGiGSJ
RT @ethanjweiss: Maybe don't stop the statin? https://t.co/Gnp9WieRc1 https://t.co/iqX9ZGiGSJ
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @mayogastro: Padecer de enfermedad cardiovascular es el factor de riesgo más importante de severidad en CoViD-19. Cuidados extremos en e…
RT @dranulala: BOOM. More data supporting understanding of #COVID19 as an endothelial disorder. @Drroxmehran @girish_nadkarni @MRMehraMD @S…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @DavidJuurlink: Three new studies in @NEJM on the safety of ACE inhibitors/ARBs in COVID-19 https://t.co/kFfescrB6f https://t.co/YXbFw…
【NEJM May 1 2020】 Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 https://t.co/Doci17n6A0
#ACE inhibitors
RT @ethanjweiss: Maybe don't stop the statin? https://t.co/Gnp9WieRc1 https://t.co/iqX9ZGiGSJ
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 | NEJM https://t.co/0cVEa76I5k
RT @PharmERToxGuy: Three new large population studies in @NEJM find ACE-Inhibitors and ARBs do NOT increase risk of #COVID19. Cardiovascula…
RT @TCHheart: New data by @HenrytTimothy and colleagues in @NEJM from 169 hospitals with 8910 COVID+ patients shows an in-hospital mortalit…
RT @ernestocardio: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 | NEJM https://t.co/I4ljIVGkB6 @mencardio @torresviera @…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
心血管系の病気や年齢と、新コロ死亡率との関係。 当初危惧された、降圧薬のACE阻害薬、ARB薬の服用は、死亡率を上げなかった。
RT @smexcardiologia: Sin duda, más evidencia para continuar las recomendaciones de @smexcardiologia y otras sociedades, para no suspender e…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @ernestocardio: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 | NEJM https://t.co/I4ljIVGkB6 @mencardio @torresviera @…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
先程の論文はイタリアからでしたが、同日の米NEJM誌ではアジア、欧州、北米からの論文も出ており、そこでもCOVID19での死亡と降圧薬であるARBsとACE阻害薬の相関を観察した結果、相関無しとの結果でてます。エビデンス2つで、ARBsとACE阻害薬中止を勧める理由は今は無いです。https://t.co/U0V9rFL1vu
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @mohaizeie: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 | NEJM https://t.co/qKzX8nzTZn
RT @DavidJuurlink: Three new studies in @NEJM on the safety of ACE inhibitors/ARBs in COVID-19 https://t.co/kFfescrB6f https://t.co/YXbFw…
RT @ethanjweiss: Maybe don't stop the statin? https://t.co/Gnp9WieRc1 https://t.co/iqX9ZGiGSJ
First paper. Observational data from 169 hospitals in Asia, Europe, and North America -> 8910 patients -> 8395 survived. It shows preexisting cardiovascular condition risk factor for COVID19 but importantly not for ACE, ARBs or antihypertensive drugs
RT @PharmERToxGuy: Three new large population studies in @NEJM find ACE-Inhibitors and ARBs do NOT increase risk of #COVID19. Cardiovascula…
AceArb in covid19 Friend of Foe
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 | NEJM https://t.co/I4ljIVGkB6 @mencardio @torresviera @igormorr @jstragazue @drjarayg @recetario1 @apoleo @Lguevaramath @DrPontecarlosi @meza0208 @mirecly2013 @emartinezgmg @GARCIAEDINSON95 @
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 | NEJM https://t.co/csCz2hjvFh
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 | NEJM - New England Journal of Medicine https://t.co/5qk1P1CReu
RT @DanielJDrucker: “Our results did not confirm previous concerns regarding a potential harmful association of ACE inhibitors or ARBs with…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @MRMehraMD: No harm of RAAS inhibitors in COVID - Potential benefit with ACE Inhibitors and Statins? Do these hypothesis generating find…
RT @MRMehraMD: No harm of RAAS inhibitors in COVID - Potential benefit with ACE Inhibitors and Statins? Do these hypothesis generating find…
RT @ethanjweiss: Maybe don't stop the statin? https://t.co/Gnp9WieRc1 https://t.co/iqX9ZGiGSJ
RT @GilbertDeray: Les barres à droite de la ligne verticale indiquent les facteurs qui augmente le risque de mortalité intra hospitalière.…
Our study confirmed previous observations suggesting that underlying #cardiovascular #disease is associated with an increased risk of in-hospital death among patients hospitalized with #Covid_19. #SARSCoV2 #coronavirus #pandemic #NEJM https://t.co/5YZod48v
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
Wow. Statin + ACEi = bulletproof?
RT @GilbertDeray: Les barres à droite de la ligne verticale indiquent les facteurs qui augmente le risque de mortalité intra hospitalière.…
RT @Hugolpi: https://t.co/yRPPmenkEu Thanks @NEJM and authors of the study. Now the picture is clearer: Risk of death in COVID19 is 79% hi…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @mencardio: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 | NEJM https://t.co/IUF0vo1ToW @ivanovich13 @torresviera @SI…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @smexcardiologia: Sin duda, más evidencia para continuar las recomendaciones de @smexcardiologia y otras sociedades, para no suspender e…